{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:45:20Z","timestamp":1793306720526,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81220108006"],"award-info":[{"award-number":["81220108006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200292"],"award-info":[{"award-number":["81200292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["15ZR1431700"],"award-info":[{"award-number":["15ZR1431700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Program of Shanghai Municipality for Basic Research","award":["10JC1412400"],"award-info":[{"award-number":["10JC1412400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s40618-019-01018-5","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T06:26:23Z","timestamp":1552112783000},"page":"1019-1027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner"],"prefix":"10.1007","volume":"42","author":[{"given":"J.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-4050","authenticated-orcid":false,"given":"Q.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"key":"1018_CR1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2337\/diacare.19.9.1018","volume":"19","author":"JD Best","year":"1996","unstructured":"Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN (1996) Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19:1018\u20131030","journal-title":"Diabetes Care"},{"key":"1018_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/01.mco.0000172588.47811.63","volume":"8","author":"J Tonelli","year":"2005","unstructured":"Tonelli J, Kishore P, Lee DE, Hawkins M (2005) The regulation of glucose effectiveness: how glucose modulates its own production. Curr Opin Clin Nutr Metab Care 8:450\u2013456","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1018_CR3","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.2337\/dc10-0165","volume":"33","author":"C Lorenzo","year":"2010","unstructured":"Lorenzo C, Wagenknecht LE, Rewers MJ, Karter AJ, Bergman RN, Hanley AJ, Haffner SM (2010) Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the insulin resistance atherosclerosis study (IRAS). Diabetes Care 33:2098\u20132103","journal-title":"Diabetes Care"},{"key":"1018_CR4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.2337\/dc10-2120","volume":"34","author":"C Lorenzo","year":"2011","unstructured":"Lorenzo C, Wagenknecht LE, Karter AJ, Hanley AJ, Rewers MJ, Haffner SM (2011) Cross-sectional and longitudinal changes of glucose effectiveness in relation to glucose tolerance: the insulin resistance atherosclerosis study. Diabetes Care 34:1959\u20131964","journal-title":"Diabetes Care"},{"key":"1018_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2337\/diacare.27.6.1439","volume":"27","author":"K Osei","year":"2004","unstructured":"Osei K, Rhinesmith S, Gaillard T, Schuster D (2004) Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 27:1439\u20131446","journal-title":"Diabetes Care"},{"key":"1018_CR6","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1172\/JCI117225","volume":"93","author":"DA D\u2019Alessio","year":"1994","unstructured":"D\u2019Alessio DA, Kahn SE, Leusner CR, Ensinck JW (1994) Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Investig 93:2263\u20132266","journal-title":"J Clin Investig"},{"key":"1018_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","volume":"20","author":"N Itoh","year":"2004","unstructured":"Itoh N, Ornitz DM (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563\u2013569","journal-title":"Trends Genet"},{"key":"1018_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","volume":"342","author":"N Itoh","year":"2010","unstructured":"Itoh N (2010) Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res 342:1\u201311","journal-title":"Cell Tissue Res"},{"key":"1018_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1507\/endocrj.KR07E-002","volume":"55","author":"S Fukumoto","year":"2008","unstructured":"Fukumoto S (2008) Actions and mode of actions of FGF19 subfamily members. Endocr J 55:23\u201331","journal-title":"Endocr J"},{"key":"1018_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1101\/gad.184788.111","volume":"26","author":"MJ Potthoff","year":"2012","unstructured":"Potthoff MJ, Kliewer SA, Mangelsdorf DJ (2012) Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine. Genes Dev 26:312\u2013324","journal-title":"Genes Dev"},{"key":"1018_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA et al (2005) FGF-21 as a novel metabolic regulator. J Clin Investig 115:1627\u20131635","journal-title":"J Clin Investig"},{"key":"1018_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1021\/mp700105z","volume":"5","author":"S Jones","year":"2008","unstructured":"Jones S (2008) Mini-review: endocrine actions of fibroblast growth factor 19. Mol Pharm 5:42\u201348","journal-title":"Mol Pharm"},{"key":"1018_CR13","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","volume":"143","author":"E Tomlinson","year":"2002","unstructured":"Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, Stephan JP, Tsai SP, Powell-Braxton L, French D, Stewart TA (2002) Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143:1741\u20131747","journal-title":"Endocrinology"},{"key":"1018_CR14","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1210\/en.2003-1671","volume":"145","author":"L Fu","year":"2004","unstructured":"Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B et al (2004) Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145:2594\u20132603","journal-title":"Endocrinology"},{"key":"1018_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","volume":"3","author":"G Marcelin","year":"2014","unstructured":"Marcelin G, Jo YH, Li X, Schwartz GJ, Zhang Y, Dun NJ, Lyu RM, Blouet C, Chang JK, Chua S Jr (2014) Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism. Mol Metab 3:19\u201328","journal-title":"Mol Metab"},{"key":"1018_CR16","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.1198363","volume":"331","author":"S Kir","year":"2011","unstructured":"Kir S, Beddow SA, Samuel VT, Miller P, Previs SF, Suino-Powell K, Xu HE, Shulman GI, Kliewer SA, Mangelsdorf DJ (2011) FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331:1621\u20131624","journal-title":"Science"},{"key":"1018_CR17","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.2337\/dc12-1766","volume":"36","author":"Q Fang","year":"2013","unstructured":"Fang Q, Li H, Song Q, Yang W, Hou X, Ma X, Lu J, Xu A, Jia W (2013) Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels. Diabetes Care 36:2810\u20132814","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"1018_CR18","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5\u2013S20","journal-title":"Diabetes Care"},{"key":"1018_CR19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2337\/diacare.26.3.868","volume":"26","author":"M Hanefeld","year":"2003","unstructured":"Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T (2003) Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in impaired glucose tolerance for atherosclerosis and diabetes study. Diabetes Care 26:868\u2013874","journal-title":"Diabetes Care"},{"key":"1018_CR20","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.2337\/dc06-0438","volume":"29","author":"C Meyer","year":"2006","unstructured":"Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909\u20131914","journal-title":"Diabetes Care"},{"key":"1018_CR21","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1038\/s41598-017-06252-6","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang J, Li H, Zhou H, Fang L, Xu J, Yan H, Chen S, Song Q, Zhang Y, Xu A et al (2017) Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose. Sci Rep 7:6042","journal-title":"Sci Rep"},{"key":"1018_CR22","first-page":"268","volume":"17","author":"W Jia","year":"2001","unstructured":"Jia W, Chen L, Xiang K, Lu J, Bao Y, Xue F, Lu W (2001) Establishment of an extended hyperinsulinemic euglycemic clamp technique. Chin J Endocrinol Metab 17:268\u2013271","journal-title":"Chin J Endocrinol Metab"},{"key":"1018_CR23","first-page":"E592","volume":"274","author":"G Pacini","year":"1998","unstructured":"Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A, Nosadini R (1998) Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol 274:E592\u2013E599","journal-title":"Am J Physiol"},{"key":"1018_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/diab.42.2.250","volume":"42","author":"GM Steil","year":"1993","unstructured":"Steil GM, Volund A, Kahn SE, Bergman RN (1993) Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 42:250\u2013256","journal-title":"Diabetes"},{"key":"1018_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20060203","volume":"112","author":"U Morbiducci","year":"2007","unstructured":"Morbiducci U, Di Benedetto G, Kautzky-Willer A, Pacini G, Tura A (2007) Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation. Clin Sci (Lond) 112:257\u2013263","journal-title":"Clin Sci (Lond)"},{"key":"1018_CR26","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1172\/JCI70710","volume":"123","author":"GJ Morton","year":"2013","unstructured":"Morton GJ, Matsen ME, Bracy DP, Meek TH, Nguyen HT, Stefanovski D, Bergman RN, Wasserman DH, Schwartz MW (2013) FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest 123:4799\u20134808","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"1018_CR27","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1007\/s00592-012-0417-y","volume":"49","author":"S Nagasaka","year":"2012","unstructured":"Nagasaka S, Kusaka I, Yamashita K, Funase Y, Yamauchi K, Katakura M, Ishibashi S, Aizawa T (2012) Index of glucose effectiveness derived from oral glucose tolerance test. Acta Diabetol 49(Suppl 1):S195\u2013S204","journal-title":"Acta Diabetol"},{"key":"1018_CR28","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1210\/jc.2007-0209","volume":"92","author":"W Jia","year":"2007","unstructured":"Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K (2007) Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 92:3224\u20133229","journal-title":"J Clin Endocrinol Metab"},{"key":"1018_CR29","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1210\/jc.2008-2331","volume":"94","author":"H Li","year":"2009","unstructured":"Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W (2009) Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab 94:2151\u20132156","journal-title":"J Clin Endocrinol Metab"},{"key":"1018_CR30","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214\u2013E223","journal-title":"Am J Physiol"},{"key":"1018_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1172\/JCI111938","volume":"76","author":"RA DeFronzo","year":"1985","unstructured":"DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Investig 76:149\u2013155","journal-title":"J Clin Investig"},{"key":"1018_CR32","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"1018_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1018_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","volume":"13","author":"MJ Potthoff","year":"2011","unstructured":"Potthoff MJ, Boney-Montoya J, Choi M, He T, Sunny NE, Satapati S, Suino-Powell K, Xu HE, Gerard RD, Finck BN et al (2011) FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway. Cell Metab 13:729\u2013738","journal-title":"Cell Metab"},{"key":"1018_CR35","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1210\/jc.2013-3273","volume":"99","author":"MB Egede","year":"2014","unstructured":"Egede MB, Henriksen JE, Durck TT, Levin K, Rantzau C, Ward G, Beck-Nielsen H, Alford FP (2014) Glucose effectiveness in nondiabetic relatives: dysglycemia and beta-cell function at 10 years. J Clin Endocrinol Metab 99:1420\u20131424","journal-title":"J Clin Endocrinol Metab"},{"issue":"38","key":"1018_CR36","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/diab.38.12.1512","volume":"1989","author":"RN Bergman","year":"1989","unstructured":"Bergman RN (1989) Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989(38):1512\u20131527","journal-title":"Diabetes"},{"key":"1018_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1210\/en.2012-1891","volume":"154","author":"KK Ryan","year":"2013","unstructured":"Ryan KK, Kohli R, Gutierrez-Aguilar R, Gaitonde SG, Woods SC, Seeley RJ (2013) Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. Endocrinology 154:9\u201315","journal-title":"Endocrinology"},{"key":"1018_CR38","doi-asserted-by":"publisher","first-page":"26687","DOI":"10.1074\/jbc.M704165200","volume":"282","author":"H Kurosu","year":"2007","unstructured":"Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M (2007) Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282:26687\u201326695","journal-title":"J Biol Chem"},{"key":"1018_CR39","doi-asserted-by":"publisher","first-page":"27277","DOI":"10.1074\/jbc.M704244200","volume":"282","author":"BC Lin","year":"2007","unstructured":"Lin BC, Wang M, Blackmore C, Desnoyers LR (2007) Liver-specific activities of FGF19 require Klotho beta. J Biol Chem 282:27277\u201327284","journal-title":"J Biol Chem"},{"key":"1018_CR40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2337\/diacare.15.3.318","volume":"15","author":"RA DeFronzo","year":"1992","unstructured":"DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318\u2013368","journal-title":"Diabetes Care"},{"key":"1018_CR41","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1172\/JCI119275","volume":"99","author":"M Ader","year":"1997","unstructured":"Ader M, Ni TC, Bergman RN (1997) Glucose effectiveness assessed under dynamic and steady state conditions Comparability of uptake versus production components. J Clin Investig 99:1187\u20131199","journal-title":"J Clin Investig"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01018-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T15:54:05Z","timestamp":1663084445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01018-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1018"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01018-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,9]]},"assertion":[{"value":"24 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}